Anavex Life Sciences is a New York biopharmaceutical company developing drug candidates for Alzheimer's and other brain diseases. It last closed at $0.59 on Nov 20, down 11.39% on the day. The next earnings report for AVXL is expected around Tue, Nov 24, 2026. For the quarter ended Jun 2026, AVXL reported EPS of $0.08. Over its last 5 reports the stock moved an average of 6.7% the session after earnings.
AI Auto Pilots
Is AVXL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AVXL.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on AVXLStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
Technical AnalysisPrices may be delayed
AVXL · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 78% below its 20 day and 162% below its 50 day average. It is 374% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 17), oversold. The nearest support is the 52 week low at $0.59, and the nearest resistance the Pivot at $0.63.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 17.9%/day
Key levels
$5.3652 week high+808.5%
$2.81200 day average+376.3%
$2.21100 day average+274.6%
$1.5550 day average+162.7%
$1.32Swing high (Oct 29)+123.7%
$1.0620 day average+79.7%
$0.67Pivot R1+13.6%
$0.63Pivot+6.8%
$0.5952 week low+0.0%
$0.59Last close
$0.55Pivot S1−6.8%
Indicators
RSI (14)
17.16
Oversold below 30
Oversold
MACD
-0.25
Below its signal line
Bearish
Stochastic
1.1
Near the bottom of its range
Oversold
ADX (14)
57.9
Strong downtrend
Williams %R
-99.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-158.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−48.6%
Change over 10 sessions
Bearish
ATR (14)
$0.11
Typical daily range, 17.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 67.7%/day
Key levels
$5.3652 week high+808.5%
$2.81200 day average+376.3%
$2.21100 day average+274.6%
$1.5550 day average+162.7%
$1.32Swing high (Oct 29)+123.7%
$1.0620 day average+79.7%
$0.67Pivot R1+13.6%
$0.63Pivot+6.8%
$0.5952 week low+0.0%
$0.59Last close
$0.55Pivot S1−6.8%
Indicators
RSI (14)
22.32
Oversold below 30
Oversold
MACD
-0.68
Below its signal line
Bearish
Stochastic
1.3
Near the bottom of its range
Oversold
ADX (14)
24.8
Weak trend
Williams %R
-100.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-138.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−77.4%
Change over 10 sessions
Bearish
ATR (14)
$0.40
Typical daily range, 67.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for AVXL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AVXL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow AVXL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for AVXLHow many large options trades hit AVXL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AVXL in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AVXL is in one of them and how their past AVXL trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Anavex Life Sciences
Anavex Life Sciences is a clinical stage biopharmaceutical company based in New York. It develops drug candidates for diseases of the central nervous system, including Alzheimer's disease, Parkinson's disease, schizophrenia, Rett syndrome and other rare brain disorders. Its main candidate, blarcamesine, is being studied as an oral treatment that acts on the sigma receptor. The company's intended customers are patients with these conditions and the healthcare providers who treat them.